BioCentury | Nov 5, 2016
Finance

Craving Biohaven

Biohaven Pharmaceutical Holding Co. Ltd. raised a tranched $80 million private round on its management team’s track record of bringing neurology compounds through the clinic, and the range of both Orphan and common indications the...
Items per page:
1 - 1 of 1